• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康与疾病状态下的心脏脂肪酸摄取与转运

Cardiac fatty acid uptake and transport in health and disease.

作者信息

van der Vusse G J, van Bilsen M, Glatz J F

机构信息

Department of Physiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands.

出版信息

Cardiovasc Res. 2000 Jan 14;45(2):279-93. doi: 10.1016/s0008-6363(99)00263-1.

DOI:10.1016/s0008-6363(99)00263-1
PMID:10728348
Abstract

Fatty acids are important energy donors for the healthy heart. These substrates are supplied to the myocardium bound to albumin to overcome their low solubility in aqueous solutions such as blood plasma. Transport from the microvascular compartment to the mitochondria inside the cardiomyocytes is most likely a combination of passive and protein-mediated diffusion. Alterations in tissue content of fatty acid-transport proteins may contribute to myocardial diseases such as the diabetic heart, and cardiac hypertrophy and failure.

摘要

脂肪酸是健康心脏重要的能量供体。这些底物与白蛋白结合后被输送到心肌,以克服它们在诸如血浆等水溶液中溶解度低的问题。从微血管腔室到心肌细胞内线粒体的转运很可能是被动扩散和蛋白质介导扩散的结合。脂肪酸转运蛋白的组织含量改变可能导致心肌疾病,如糖尿病性心肌病、心脏肥大和心力衰竭。

相似文献

1
Cardiac fatty acid uptake and transport in health and disease.健康与疾病状态下的心脏脂肪酸摄取与转运
Cardiovasc Res. 2000 Jan 14;45(2):279-93. doi: 10.1016/s0008-6363(99)00263-1.
2
Regulation of energy substrate metabolism in the diabetic heart.糖尿病心脏中能量底物代谢的调节。
Cardiovasc Res. 1997 Apr;34(1):25-33. doi: 10.1016/s0008-6363(97)00047-3.
3
Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.心脏胰岛素抵抗和线粒体能量产生减少先于压力超负荷肥厚后收缩性心力衰竭的发展。
Circ Heart Fail. 2013 Sep 1;6(5):1039-48. doi: 10.1161/CIRCHEARTFAILURE.112.000228. Epub 2013 Jul 16.
4
Regulatory networks controlling mitochondrial energy production in the developing, hypertrophied, and diabetic heart.调控发育中、肥大及糖尿病心脏线粒体能量产生的调控网络。
Cold Spring Harb Symp Quant Biol. 2002;67:371-82. doi: 10.1101/sqb.2002.67.371.
5
Diabetic cardiomyopathy.糖尿病性心肌病
Arch Mal Coeur Vaiss. 2004 Mar;97(3):261-5.
6
AMPK signalling and the control of substrate use in the heart.AMPK 信号通路与心脏中底物利用的调控
Mol Cell Endocrinol. 2013 Feb 25;366(2):180-93. doi: 10.1016/j.mce.2012.06.015. Epub 2012 Jun 28.
7
Fatty acid-binding proteins in the heart.心脏中的脂肪酸结合蛋白
Mol Cell Biochem. 1998 Mar;180(1-2):43-51.
8
[Molecular mechanisms of the changes in myocardial energy metabolism in pathology].[病理学中心肌能量代谢变化的分子机制]
Kardiologiia. 1980 May;20(5):10-2.
9
Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes.心肌代谢及其与心肌细胞收缩、生长和存活的相互作用。
Circ Res. 2013 Aug 16;113(5):603-16. doi: 10.1161/CIRCRESAHA.113.302095.
10
Prostaglandin E receptor subtype 4 protects against diabetic cardiomyopathy by modulating cardiac fatty acid metabolism via FOXO1/CD36 signalling.前列腺素 E 受体亚型 4 通过调节 FOXO1/CD36 信号通路影响心脏脂肪酸代谢,从而对糖尿病心肌病起到保护作用。
Biochem Biophys Res Commun. 2021 Apr 9;548:196-203. doi: 10.1016/j.bbrc.2021.01.038. Epub 2021 Feb 26.

引用本文的文献

1
Effect of Empagliflozin on the plasma lipidome in patients with type 2 diabetes mellitus: results from the EmDia clinical trial.恩格列净对2型糖尿病患者血浆脂质组的影响:EmDia临床试验结果
Cardiovasc Diabetol. 2025 Sep 8;24(1):359. doi: 10.1186/s12933-025-02916-0.
2
Carnitine Deficiency in Chronic Kidney Disease: Pathophysiology, Clinical Implications, and Therapeutic Perspectives.慢性肾脏病中的肉碱缺乏:病理生理学、临床意义及治疗前景
Nutrients. 2025 Jun 23;17(13):2084. doi: 10.3390/nu17132084.
3
Energy metabolism in cardiovascular diseases: unlocking the hidden powerhouse of cardiac pathophysiology.
心血管疾病中的能量代谢:揭开心脏病理生理学的隐藏动力源
Front Endocrinol (Lausanne). 2025 Jun 5;16:1617305. doi: 10.3389/fendo.2025.1617305. eCollection 2025.
4
Refining the link between obesity and heart failure: insights from GLP-1 receptor agonist trials and studies adopting direct adiposity measures.细化肥胖与心力衰竭之间的联系:来自胰高血糖素样肽-1受体激动剂试验及采用直接肥胖测量方法的研究的见解。
Cardiovasc Diabetol. 2025 May 22;24(1):224. doi: 10.1186/s12933-025-02778-6.
5
Role of metabolic dysfunction-associated fatty liver disease in atrial fibrillation and heart failure: molecular and clinical aspects.代谢功能障碍相关脂肪性肝病在心房颤动和心力衰竭中的作用:分子与临床层面
Front Cardiovasc Med. 2025 Apr 8;12:1573841. doi: 10.3389/fcvm.2025.1573841. eCollection 2025.
6
Hidden β-γ Dehydrogenation Products in Long-Chain Fatty Acid Oxidation Unveiled by NMR: Implications on Lipid Metabolism.核磁共振揭示长链脂肪酸氧化中的隐藏β-γ脱氢产物:对脂质代谢的影响
ACS Bio Med Chem Au. 2025 Mar 15;5(2):262-267. doi: 10.1021/acsbiomedchemau.4c00140. eCollection 2025 Apr 16.
7
Dysregulated fatty acid metabolism in pericardiac adipose tissue of pulmonary hypertension due to left heart disease mice.左心疾病所致肺动脉高压小鼠的心周脂肪组织中脂肪酸代谢失调
FASEB J. 2025 Feb 15;39(3):e70355. doi: 10.1096/fj.202402842R.
8
Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy.自然发生肥厚型心肌病猫的代谢异常与重编程
ESC Heart Fail. 2025 Apr;12(2):1256-1270. doi: 10.1002/ehf2.15135. Epub 2024 Nov 5.
9
Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond.心肌能量代谢的进展:心力衰竭及其他情况下的代谢重塑
Cardiovasc Res. 2024 Dec 14;120(16):1996-2016. doi: 10.1093/cvr/cvae231.
10
Characteristics of gene expression in epicardial adipose tissue and subcutaneous adipose tissue in patients at risk for heart failure undergoing coronary artery bypass grafting.行冠状动脉旁路移植术的心力衰竭高危患者心外膜脂肪组织和皮下脂肪组织的基因表达特征。
BMC Genomics. 2024 Oct 7;25(1):938. doi: 10.1186/s12864-024-10851-9.